Placebo-Controlled Study of AminoTriComplex in Metastatic Prostate Cancer: Regulation of Key Biomarkers, Sharp Decrease in PSA and Proinflammatory Cytokines, and Clinical Improvement in 95% of Patients
Background: Metastatic prostate cancer remains one of the leading causes of cancer

